Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. (2020)

First Author: Dogar O

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(20)30312-0

PubMed Identifier: 33069301

Publication URI: http://europepmc.org/abstract/MED/33069301

Type: Journal Article/Review

Volume: 8

Parent Publication: The Lancet. Global health

Issue: 11

ISSN: 2214-109X